Anakinra in Dengue With Hyperinflammation ( AnaDen )

NCT05611710 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Dengue
Dengue With Warning Signs
Severe Dengue
Anakinra
Immuno-modulation
Anti-inflammatory Agents
Macrophage Activation Syndrome
Hyperinflammatory Syndrome
Cytokine Storm

Interventions

DRUG: Placebo
DRUG: Anakinra

Sponsor

Oxford University Clinical Research Unit, Vietnam

Collaborators

[object Object]
[object Object]